Sab Biotherapeutics Inc. (SABS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 54
-0.12
-3.4106%
$
34.41M Market Cap
0.1 P/E Ratio
- Div Yield
678,400 Volume
0 Eps
$ 3.67
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks | 11 months ago
